BACKGROUND: Hypovitaminosis D has been associated with an increased prevalence of Type 2 diabetes mellitus (DMT2) and metabolic syndrome manifestations. The purpose of this study was to examine the association between 25-hydroxy-vitamin D (25-OH-VitD) levels and indices of insulin resistance (IR), including adipocytokines, in a Saudi population with or without DMT2. SUBJECTS AND METHODS: A total of 266 subjects (153 DMT2 and 113 healthy controls) aged 26-80 yr were randomly selected from the existing Biomarkers Screening in Riyadh Program (RIYADH Cohort). Subjects were assessed clinically, anthropometry was performed, morning blood chemistries, including fasting glucose (FG), triglycerides, total cholesterol, LDL cholesterol (LDL-C), and HDL cholesterol were obtained. Homeostasis model assessment of IR (HOMA-IR) was calculated, and serum 25-OH-VitD, leptin, adiponectin, resistin, insulin, high sensitivity CRP (hsCRP), and tumor necrosis factor α concentrations were measured using specific assays. RESULTS: In DMT2 subjects, negative correlations between 25-OH-vitD and body mass index (BMI), FG, insulin, HOMA-IR, cholesterol, LDL-C, and hsCRP were observed, while a positive correlation between 25-OH-VitD and adiponectin was detected. The later remained significant after controlling for BMI. Interestingly, only weak and nonsignificant associations between 25-OH-VitD and metabolic parameters were observed in the control group, whereas, when the entire population was examined, negative correlations were evident primarily between 25-OH-VitD and FG, HOMA-IR, total cholesterol, LDL-C. These associations remained significant after controlling for BMI. CONCLUSIONS: These results suggest that hypovitaminosis D associations with metabolic disturbances are accentuated in DMT2. The BMIindependent positive correlation between 25-OH-VitD and adiponectin suggests a potential role for this adipocytokine as a link between 25-OH-VitD and IR in patients with DMT2.
BACKGROUND: Hypovitaminosis D has been associated with an increased prevalence of Type 2 diabetes mellitus (DMT2) and metabolic syndrome manifestations. The purpose of this study was to examine the association between 25-hydroxy-vitamin D (25-OH-VitD) levels and indices of insulin resistance (IR), including adipocytokines, in a Saudi population with or without DMT2. SUBJECTS AND METHODS: A total of 266 subjects (153 DMT2 and 113 healthy controls) aged 26-80 yr were randomly selected from the existing Biomarkers Screening in Riyadh Program (RIYADH Cohort). Subjects were assessed clinically, anthropometry was performed, morning blood chemistries, including fasting glucose (FG), triglycerides, total cholesterol, LDL cholesterol (LDL-C), and HDL cholesterol were obtained. Homeostasis model assessment of IR (HOMA-IR) was calculated, and serum 25-OH-VitD, leptin, adiponectin, resistin, insulin, high sensitivity CRP (hsCRP), and tumor necrosis factor α concentrations were measured using specific assays. RESULTS: In DMT2 subjects, negative correlations between 25-OH-vitD and body mass index (BMI), FG, insulin, HOMA-IR, cholesterol, LDL-C, and hsCRP were observed, while a positive correlation between 25-OH-VitD and adiponectin was detected. The later remained significant after controlling for BMI. Interestingly, only weak and nonsignificant associations between 25-OH-VitD and metabolic parameters were observed in the control group, whereas, when the entire population was examined, negative correlations were evident primarily between 25-OH-VitD and FG, HOMA-IR, total cholesterol, LDL-C. These associations remained significant after controlling for BMI. CONCLUSIONS: These results suggest that hypovitaminosis D associations with metabolic disturbances are accentuated in DMT2. The BMIindependent positive correlation between 25-OH-VitD and adiponectin suggests a potential role for this adipocytokine as a link between 25-OH-VitD and IR in patients with DMT2.
Authors: G Maalouf; M H Gannagé-Yared; J Ezzedine; B Larijani; S Badawi; A Rached; L Zakroui; B Masri; E Azar; E Saba; R Nammari; G Adib; H Abou Samra; Z Alrawi; S Salman; K El Muntasser; R Tarseen; W El Kharousi; M Al-Lamki; A N Alothman; N Almarzook; M El Dessouki; R Sulaimani; J Saleh; A R Suhaili; A Khan; P Delmas; E Seeman Journal: J Musculoskelet Neuronal Interact Date: 2007 Apr-Jun Impact factor: 2.041
Authors: William G Petchey; Ingrid J Hickman; Emma Duncan; Johannes B Prins; Carmel M Hawley; David W Johnson; Katherine Barraclough; Nicole M Isbel Journal: BMC Nephrol Date: 2009-12-10 Impact factor: 2.388
Authors: Mansour K Al-Zahrani; Abdulrahman M Elnasieh; Farhan M Alenezi; Abdulrahman A Almoushawah; Mohammed Almansour; Fahad Alshahrani; Saeed Ur Rahman; Abdullah Al-Zahrani Journal: Int J Clin Exp Med Date: 2014-12-15
Authors: I Perez-Diaz; G Sebastian-Barajas; Z G Hernandez-Flores; R Rivera-Moscoso; H K Osorio-Landa; A Flores-Rebollar Journal: J Endocrinol Invest Date: 2015-12 Impact factor: 4.256
Authors: Nasser M Al-Daghri; Yousef Al-Saleh; Naji Aljohani; Majed Alokail; Omar Al-Attas; Abdullah M Alnaami; Shaun Sabico; Maha Alsulaimani; Mohammed Al-Harbi; Hanan Alfawaz; George P Chrousos Journal: PLoS One Date: 2015-07-17 Impact factor: 3.240
Authors: Ji A Seo; Chai Ryoung Eun; Hyunjoo Cho; Seung Ku Lee; Hye Jin Yoo; Sin Gon Kim; Kyung Mook Choi; Sei Hyun Baik; Dong Seop Choi; Hyung Joon Yim; Chol Shin; Nan Hee Kim Journal: PLoS One Date: 2013-10-09 Impact factor: 3.240